Cargando…

Evolution of resistance in paediatric patients with failure on antiretroviral therapy

INTRODUCTION: HIV-1 resistance data to inform treatment sequencing are limited for children with virological failure on first- and second-line antiretroviral therapy (ART) in Sub-Saharan Africa. METHODS: HIV-1-infected children aged ≤15 years were retrospectively identified from an ART cohort in Cap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orrell, C, Levison, J, Ciaranello, A, Bekker, L, Kuritzkes, D, Freedberg, K, Wood, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2012
Materias:	Oral Abstract – O225
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512453/ http://dx.doi.org/10.7448/IAS.15.6.18086

Ejemplares similares

Can urban gardens improve food security, health, well-being and financial sustainability of households?
por: Guerreiro, Helena, et al.
Publicado: (2021)

Time to virologic failure for patients taking their first antiretroviral regimen and the subsequent resistance profiles
por: Crouzat, Frederic, et al.
Publicado: (2014)

Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without Resistance in a Large HIV Treatment Program in South Africa
por: Levison, Julie H., et al.
Publicado: (2012)

HISTOPLASMOSE DISSEMINADA: MANIFESTAÇÃO CLÍNICA INICIAL DE PACIENTE AIDS COM COINFECÇÃO PELO SARS‐COV2
por: Barroso, Harianne Gedeon B., et al.
Publicado: (2021)

RÁPIDA INSERÇÃO E DISSEMINAÇÃO DA RESISTÊNCIA BACTERIANA EM UMA UNIDADE COVID E O IMPACTO NO TRATAMENTO ANTIMICROBIANO EMPÍRICO DE PACIENTES COM BACTEREMIA
por: Chagas, Alan Pereira, et al.
Publicado: (2022)

Eliminating paediatric infections and keeping mothers alive
por: Gray, G
Publicado: (2012)

Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients
por: Lamorde, M
Publicado: (2012)

Life expectancy of HIV-1-positive individuals approaches normal conditional on response to antiretroviral therapy: UK Collaborative HIV Cohort Study
por: May, M, et al.
Publicado: (2012)

Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection
por: Thornhill, John, et al.
Publicado: (2014)

Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant
por: Scarsi, Kimberly, et al.
Publicado: (2014)

Effectiveness of a reduced dose of efavirenz plus 2 NRTIs as maintenance antiretroviral therapy with the guidance of therapeutic drug monitoring
por: Yang, Shang-Ping, et al.
Publicado: (2014)

Antiviral activity of dolutegravir in subjects with failure on an integrase inhibitor-based regimen: week 24 phase 3 results from VIKING-3
por: Nichols, G, et al.
Publicado: (2012)

Predicted savings to the UK National Health Service from switching to generic antiretrovirals, 2014–2018
por: Hill, Andrew, et al.
Publicado: (2014)

HIV drug resistance surveillance in low- and middle-income countries: 2004 to 2010
por: Bertagnolio, S, et al.
Publicado: (2012)

Does early initiation of ART in infants affect virological and resistance outcomes? Data from the CHER trial after 6 years of follow-up
por: Violari, A, et al.
Publicado: (2012)

Managing first-line failure
por: Cooper, David A
Publicado: (2014)

725 Evaluating Wound Care Compliance, Healing and Perceptions in Burn Patients Discharged to Post-Acute Care Facilities
por: Osborn, Suzanne, et al.
Publicado: (2023)

726 Enteral Tube Clogging and Medication Administration Techniques
por: Rathjen, Esther, et al.
Publicado: (2023)

728 A Survey of Health Professionals' Attitudes Regarding Substance Abuse Disorder in Burn Patients
por: Richey, Karen, et al.
Publicado: (2023)

729 A Post-Pandemic Educational Program for New Burn Nurses
por: Klinkhamer, Angela, et al.
Publicado: (2023)

727 Development of an Acuity and Scheduling System for Wound Care
por: Salazar, Elizabeth, et al.
Publicado: (2023)

730 Geographic Effects of Rural Burn Care Follow Up During the COVID-19 Pandemic
por: Bradshaw, Evan, et al.
Publicado: (2023)

Currently available medications may not be sufficient for lifelong treatment of HIV
por: Jansson, J, et al.
Publicado: (2012)

More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV Cohort
por: Rokx, Casper, et al.
Publicado: (2014)

Rate of viral load failure over time in people on ART in the UK Collaborative HIV Cohort (CHIC) study
por: O'Connor, Jemma, et al.
Publicado: (2014)

Choice of initial therapy
por: Battegay, Manuel
Publicado: (2014)

When to start: as soon as possible
por: Saag, M
Publicado: (2012)

When to start: not so fast
por: Lundgren, J
Publicado: (2012)

Late presenters: what can we do?
por: Mussini, C
Publicado: (2012)

TB and HIV: how can we reduce mortality?
por: Lawn, S
Publicado: (2012)

Treatment optimization in low- and middle-income countries
por: Cooper, D
Publicado: (2012)

HIV, co-morbidity and ageing
por: Reiss, P
Publicado: (2012)

Review of life expectancy in people with HIV in settings with optimal ART access: what we know and what we don't
por: Sabin, C
Publicado: (2012)

HIV in women
por: Mulcahy, F
Publicado: (2012)

HAART rollout in the new fiscal and economic environment
por: Moatti, J
Publicado: (2012)

Safety profile of HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 analysis
por: Lalezari, Jacob, et al.
Publicado: (2014)

HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 sub-group analysis
por: Brinson, Cynthia, et al.
Publicado: (2014)

Management of drug-resistant TB in patients with HIV co-infection
por: Meintjes, Graeme
Publicado: (2014)

Resistance: what is new and on the horizon, and a time to teach old dogs new tricks?
por: Schapiro, Jonathan
Publicado: (2014)

The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound
por: Wainberg, Mark, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vsnffu0r0tphu8g3orcpbi0fc7